Literature DB >> 17448568

Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner.

Yongyan Chen1, Rui Sun, Wei Jiang, Haiming Wei, Zhigang Tian.   

Abstract

BACKGROUND/AIMS: The role of natural killer (NK) cells in the development of hepatitis B virus (HBV)-associated liver injury remains obscure. In this study, we elucidated the role of NK cells in liver injury of HBsAg transgenic mice (HBs-B6), a mimic of human healthy chronic HBsAg carriers, triggered by polyinosinic:polycytidylic acid [Poly(I:C)].
METHODS: HBs-B6 or wild B6 mice were intraperitoneally injected with Poly(I:C) at different doses. Liver injury was evaluated by serum transaminase activity and histopathologic changes.
RESULTS: HBs-B6 mice were over-sensitive to Poly(I:C)-induced liver injury, which was absolutely dependent on the presence of NK cells and IFN-gamma produced by intrahepatic NK cells. Much stronger IFN-gamma receptor expression was observed on hepatocytes of HBs-B6 mice, which was significantly enhanced by Poly(I:C) injection. Treatment with IFN-gammain vitro triggered much higher activation of downstream signals (pSTAT1-IRF-1) in hepatocytes of HBs-B6 mice. Depletion of Kupffer cells and neutralization of endogenous IL-12 did not affect Poly(I:C)-induced over-sensitive liver injury in HBs-B6 mice.
CONCLUSIONS: NK cells played a critical role in an IFN-gamma dependent, Kupffer cell- and IL-12-independent manner in over-sensitive liver injury triggered by Poly(I:C) in murine chronic HBsAg carriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448568     DOI: 10.1016/j.jhep.2007.02.020

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  22 in total

1.  Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.

Authors:  Q Zheng; Y Y Zhu; J Chen; Y B Ye; J Y Li; Y R Liu; M L Hu; Y C Zheng; J J Jiang
Journal:  Clin Exp Immunol       Date:  2015-04-12       Impact factor: 4.330

Review 2.  NK cells in immunotolerant organs.

Authors:  Haoyu Sun; Cheng Sun; Zhigang Tian; Weihua Xiao
Journal:  Cell Mol Immunol       Date:  2013-04-08       Impact factor: 11.530

Review 3.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

4.  γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice.

Authors:  Ziyu Meng; Jingya Wang; Yifang Yuan; Guangchao Cao; Shuobing Fan; Chao Gao; Li Wang; Zheng Li; Xiaoli Wu; Zhenzhou Wu; Liqing Zhao; Zhinan Yin
Journal:  Immunology       Date:  2017-02-20       Impact factor: 7.397

Review 5.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response.

Authors:  Dilip Ratnam; Kumar Visvanathan
Journal:  Hepatol Int       Date:  2008-02-27       Impact factor: 6.047

7.  Effect of polyI:C cotreatment on halothane-induced liver injury in mice.

Authors:  Linling Cheng; Qiang You; Hao Yin; Michael Holt; Christopher Franklin; Cynthia Ju
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 8.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.

Authors:  Bin Gao; Svetlana Radaeva; Ogyi Park
Journal:  J Leukoc Biol       Date:  2009-09       Impact factor: 4.962

9.  Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.

Authors:  Ian Baudi; Masanori Isogawa; Federica Moalli; Masaya Onishi; Keigo Kawashima; Yuji Ishida; Chise Tateno; Yusuke Sato; Hideyoshi Harashima; Hiroyasu Ito; Tetsuya Ishikawa; Takaji Wakita; Matteo Iannacone; Yasuhito Tanaka
Journal:  PLoS Pathog       Date:  2021-05-12       Impact factor: 6.823

Review 10.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.